Compare QDEL & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QDEL | CBLL |
|---|---|---|
| Founded | 1979 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 989.5M | 935.3M |
| IPO Year | 2022 | 2024 |
| Metric | QDEL | CBLL |
|---|---|---|
| Price | $13.33 | $27.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $14.67 | ★ $28.57 |
| AVG Volume (30 Days) | ★ 2.0M | 380.0K |
| Earning Date | 11-03-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 45.35 | ★ 56.93 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,730,200,000.00 | $89,063,000.00 |
| Revenue This Year | N/A | $29.66 |
| Revenue Next Year | $1.85 | $27.36 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 36.09 |
| 52 Week Low | $9.92 | $10.85 |
| 52 Week High | $35.58 | $28.11 |
| Indicator | QDEL | CBLL |
|---|---|---|
| Relative Strength Index (RSI) | 53.87 | 60.89 |
| Support Level | $13.04 | $22.64 |
| Resistance Level | $17.86 | N/A |
| Average True Range (ATR) | 1.09 | 1.51 |
| MACD | 0.19 | 0.24 |
| Stochastic Oscillator | 67.80 | 86.34 |
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.
CeriBell Inc is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable, and rapidly deployable hardware with sophisticated artificial intelligence (AI)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. Its products are Point-of-Care EEG, Clarity, and EEG Portal.